Skip to content

Comfort Check of CO2 Monitoring Cannulas With Oxygen Delivery

Comfort Check of CO2 Monitoring Cannulas With Oxygen Delivery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03109132
Enrollment
60
Registered
2017-04-12
Start date
2017-04-23
Completion date
2017-08-30
Last updated
2017-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wearing Comfort

Brief summary

The purpose of this test is to evaluate the comfort level of several model configurations of the Smart CapnoLine plus cannula The test focuses on the comfort / discomfort generated by the device, mainly due to tubes around the ears and on the face skin, the cannula itself (especially in the nostrils and the mouth surrounding) and the smell.

Detailed description

This test compares 4 models for the duration of up to 3 days each and 2 models with duration of up to 24 hours. Each subject will tested the models and will provide feedback at predefined times during the test. During the test and according to initial result the team may decide to shorten the test duration. The testing staff will include a dermatologist and a technical representative that will supervise the test in order to monitor and control the required performance of the subjects according to test protocol, and relevant outcomes. During the test the dermatologist will monitor any unexpected skin reaction or patient discomfort.

Interventions

DEVICEOridion Smart CapnoLine® H Plus with Wedge cannula

The subjects will assess the comfort level of the different cannulas

DEVICEOridion Smart CapnoLine® Plus with Non-Wedge cannula

The subjects will assess the comfort level of the different cannulas

DEVICEExperimental sample line Model 3

The subjects will assess the comfort level of the different cannulas

DEVICEExperimental sample line Model 4

The subjects will assess the comfort level of the different cannulas

DEVICEExperimental sample line Model 5

The subjects will assess the comfort level of the different cannulas

DEVICEO2/CO2 cannula w/female luer (Westmed comfort plus #0504)

The subjects will assess the comfort level of the different cannulas

Sponsors

Institute for Skin Research, Israel
CollaboratorINDUSTRY
Medtronic - MITG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DEVICE_FEASIBILITY
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

This is a double-blind, order randomized study. All cannulas will be numbered. The investigators, the outcomes assessors and the subjects will be blind to the identity of the cannulas. The order of which the subjects will assess the cannulas will be randomized.

Intervention model description

This is randomnized crossover study. Every subject will assess all cannulas in randomized order.

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy Volunteers * Men and Women * Age 50-85 * Willingness to participate in the study

Exclusion criteria

* Women who are pregnant or breastfeeding * Subjects with sensitivity to any of the products or the its ingredient * Subjects with sensitivity to preparation for testing bacterial plaque * Subjects who are treated with anti inflammatory antihistamine corticosteroids treatment * Subjects who are treated with Anti-thrombotic agents

Design outcomes

Primary

MeasureTime frameDescription
Comfort evaluation using self introduction questionnaire3 monthsMeasuring comfort on a scale of 1 -7, where 1 = not comfortable, 7 = very comfortable Data will be reported using self introduction questionnaires in different time intervals

Secondary

MeasureTime frameDescription
Comfort evaluation using self introduction questionnaire - calculations3 monthsThe average comfort will be calculated for each time interval and for the all period. The values has no units, this is a subjective evaluation and not clinical value measured.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026